Pfizer
235 East 42nd Street
New York, NY 10017
United States
Tel: (212) 733-2323
Website: https://www.pfizer.com/
5518 articles about Pfizer
-
Natco Pharma Limited Seeks 'Compulsory License' For Copy Of Pfizer Inc. Drug
1/5/2011
-
Alabama Judge Preps for Thousands of Pfizer Inc., Chantix Lawsuits
1/5/2011
-
Santaris Pharma A/S Announces Expanded Worldwide Strategic Alliance With Pfizer Inc.; Santaris Gets $14M Upfront, Eligible for Milestone Payments up to $600M
1/4/2011
-
AstraZeneca PLC's Brennan Poaches Pfizer Inc. to Rebuild Research
1/3/2011
-
Pfizer Inc.'s Kindler Quits the Federal Reserve Bank of New York
12/30/2010
-
Akorn, Inc. Announces the Sale of the Akorn-Strides Joint Venture Product Portfolio to Pfizer Inc. For $35 million
12/30/2010
-
Suicides May be Linked to Pfizer Inc.'s Smoking Drug
12/29/2010
-
GlaxoSmithKline Offers to Give National Cancer Institute Rebate If Pfizer Inc. Cancer Drug Better in Head to Head Clinical Trial
12/29/2010
-
Pfizer Inc., Bristol-Myers Squibb Company Blood Thinner Apixaban Beats Sanofi-Aventis (France) Drug Lovenox in Study
12/28/2010
-
Pfizer Inc. Submits Applications to FDA and European Medicines Evaluation Agency for Use of its Pneumococcal Conjugate Vaccine, Prevnar 13(R), in Adults 50 and Older
12/27/2010
-
Pfizer Inc. Japan Spin-Out RaQualia Inks New R&D, Licensing Deals
12/22/2010
-
Ligand Pharmaceuticals Inc. Earns $1 Million Upfront Payment from Pfizer Inc. on Sublicensing of Tanaproget
12/22/2010
-
Pfizer Inc. Settles Two Prempro Cases
12/21/2010
-
Pfizer Inc. Recalls More Bottles Of 40 mg Lipitor
12/21/2010
-
Adolor Corporation, Pfizer Inc. End Drug Development Alliance
12/21/2010
-
Phylogica Ltd. And Pfizer Inc. Sign Vaccines Deal Potentially Worth More than $134 Million
12/20/2010
-
Lpath, Inc. Grants Pfizer Inc. Exclusive Option for Worldwide License for iSONEP; Lpath to Receive $14 Million Upfront Plus Eligible for $497.5 Million
12/20/2010
-
Icagen, Inc. and Pfizer Inc. Initiate Phase I Trial in Nav1.7 Program
12/20/2010
-
DiaGenic ASA and Pfizer Inc. to Collaborate on Blood Based Biomarkers for Early Stages of Alzheimer’s Disease
12/17/2010
-
Pfizer Inc. Extends $3.6 Billion Tender Offer To Acquire King Pharmaceuticals®, Inc.
12/16/2010